Sold as Prolixin, Permitil. Every FDA application for this active ingredient: 5 branded and 36 generic.
As of Nov 15, 2026, FDA lists 41 applications for Fluphenazine Hydrochloride (sold as Prolixin, Permitil), first approved Sep 9, 1959, with 0 new uses approved and 0 published complete response letters.
| Fluphenazine HCl | Part D | $23.3M | -15% | 24,027 |
| FLUPHENAZINE HCL | Part B | $3K | New | 39 |
| Sep 9, 1959 | PermitilNDA 12034 · New molecular entity | Schering | 7 | Discontinued |
| Dec 23, 1959 | ProlixinNDA 12145 · New dosage form | Apothecon | 12 | Discontinued |
| Jun 24, 1960 | PermitilNDA 12419 · New dosage form | Schering | 0 | Discontinued |
| Aug 24, 1960 | ProlixinNDA 11751 · New formulation or manufacturer | Apothecon | 36 | Discontinued |
| Apr 7, 1965 | PermitilNDA 16008 · New dosage form | Schering | 9 | Discontinued |
| Nov 7, 1985 | ProlixinANDA 70533 | Apothecon | 10 | Discontinued |
| Apr 16, 1987 | Fluphenazine HydrochlorideANDA 89556 | Fresenius Kabi USA | 9 | Marketed |
| Oct 16, 1987 | Fluphenazine HydrochlorideANDA 89585 | Sandoz | 14 | Marketed |
| Oct 16, 1987 | Fluphenazine HydrochlorideANDA 89586 | Sandoz | 16 | Discontinued |
| Aug 12, 1988 | Fluphenazine HydrochlorideANDA 89804 | Prasco | 14 | Discontinued |
| Aug 25, 1988 | Fluphenazine HydrochlorideANDA 89740 | Lannett | 15 | Marketed |
| Aug 25, 1988 | Fluphenazine HydrochlorideANDA 89742 | Lannett | 16 | Marketed |
| Aug 25, 1988 | Fluphenazine HydrochlorideANDA 89743 | Lannett Co Inc | 17 | Marketed |
| Aug 25, 1988 | Fluphenazine HydrochlorideANDA 89741 | Lannett | 15 | Marketed |
| Aug 30, 1991 | Fluphenazine HydrochlorideANDA 73058 | Ani Pharms | 10 | Discontinued |
| Apr 29, 1993 | Fluphenazine HydrochlorideANDA 81310 | Ani Pharms | 5 | Discontinued |
| Aug 21, 1996 | Fluphenazine HydrochlorideANDA 40146 | Pharm Assoc | 5 | Marketed |
| Sep 16, 1996 | Fluphenazine HydrochlorideANDA 74725 | Pharm Assoc | 5 | Marketed |
| Jul 9, 2020 | Fluphenazine HydrochlorideANDA 213647 | Amneal | 1 | Marketed |
| Jan 7, 2021 | Fluphenazine HydrochlorideANDA 214534 | Dr Reddys | 1 | Marketed |
| Mar 1, 2021 | Fluphenazine HydrochlorideANDA 214674 | Novitium Pharma | 1 | Marketed |
| May 27, 2021 | Fluphenazine HydrochlorideANDA 214552 | Zydus Lifesciences | 1 | Marketed |
| Oct 20, 2021 | Fluphenazine HydrochlorideANDA 215141 | Chartwell Rx | 1 | Marketed |
| Apr 1, 2022 | Fluphenazine HydrochlorideANDA 215848 | Twi Pharms | 1 | Discontinued |
| Apr 14, 2022 | Fluphenazine HydrochlorideANDA 215674 | Taro | 1 | Marketed |
| Jul 15, 2022 | Fluphenazine HydrochlorideANDA 216649 | Apotex | 1 | Discontinued |
| Oct 24, 2022 | Fluphenazine HydrochlorideANDA 213784 | Upsher Smith Labs | 1 | Marketed |
| Nov 15, 2022 | Fluphenazine HydrochlorideANDA 216891 | Breckenridge | 1 | Discontinued |
| Jan 5, 2023 | Fluphenazine HydrochlorideANDA 217410 | Ajanta Pharma Ltd | 1 | Marketed |
| Aug 18, 2023 | Fluphenazine HydrochlorideANDA 218055 | Aurobindo Pharma Ltd | 1 | Marketed |
| Sep 11, 2023 | Fluphenazine HydrochlorideANDA 217189 | Msn | 1 | Marketed |
| Nov 6, 2023 | Fluphenazine HydrochlorideANDA 216350 | Glenmark Pharms Ltd | 1 | Marketed |
| Jan 22, 2024 | Fluphenazine HydrochlorideANDA 217094 | Torrent | 0 | Discontinued |
| Jun 7, 2024 | Fluphenazine HydrochlorideANDA 218283 | Rising | 1 | Marketed |
| Jul 23, 2024 | Fluphenazine HydrochlorideANDA 218173 | Alembic | 1 | Marketed |
| Nov 18, 2025 | Fluphenazine HydrochlorideANDA 218769 | Hetero Labs Ltd Iii | 0 | Marketed |
| — | Fluphenazine HydrochlorideANDA 88527 | Watson Labs | 0 | Discontinued |
| — | Fluphenazine HydrochlorideANDA 88544 | Watson Labs | 0 | Discontinued |
| — | Fluphenazine HydrochlorideANDA 88550 | Watson Labs | 0 | Discontinued |
| — | Fluphenazine HydrochlorideANDA 88555 | Watson Labs | 0 | Discontinued |
| — | Fluphenazine HclANDA 89800 | Quad Pharms | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA